Last decade of advances in gastric neuroendocrine tumors: Innovations, challenges, and future directions

doi:10.5306/wjco.v16.i5.104577

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

HTML

Figures (1-1)

Tables (1-1)

Sum=0

May 24, 2025 (publication date) through May 19, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Clin Oncol. May 24, 2025; 16(5): 104577
Published online May 24, 2025. doi: 10.5306/wjco.v16.i5.104577

Last decade of advances in gastric neuroendocrine tumors: Innovations, challenges, and future directions

Grigorios Christodoulidis, Marina Nektaria Kouliou, Dimitrios Ragias, Dimitrios Chatziisaak, Eirini Sara Agko, Dimitrios Schizas, Dimitrios Zacharoulis

Grigorios Christodoulidis, Department of General Surgery, University Hospital of Larissa, Larissa 41110, Thessalia, Greece

Marina Nektaria Kouliou, Department of Internal Medicine, General Hospital of Argolida-Hospital Unit of Nafplio, Nafplio 21100, Pelopónnisos, Greece

Dimitrios Ragias, Department of Oncology, 251 Air Force General Hospital, Athens 11525, Greece

Dimitrios Chatziisaak, Department of Surgery, Kantonsspital St.Gallen, St.Gallen 9000, Switzerland

Dimitrios Chatziisaak, Department of Surgery, Centre Hospitalier Universitaire Vaudois, Lausanne 1005, Switzerland

Eirini Sara Agko, Department of Intensive Care Unit, Asklepios Paulinen Clinic Wiesbaden, Wiesbaden 65197, Germany

Dimitrios Schizas, Department of Surgery, National and Kapodistrian University of Athens, Athens 11527, Greece

Dimitrios Zacharoulis, Department of General Surgery, University of Thessaly, Larisa 41110, Thessalia, Greece

Author contributions: Christodoulidis G designed the overall concept and outline of the manuscript; Kouliou MN, Ragias D, Chatziisaak D, Agko ES, Schizas D, Zacharoulis D contributed to writing and editing the manuscript and to the review of the literature; Christodoulidis G, Kouliou MN, Ragias D, Chatziisaak D, Agko ES, Schizas D, Zacharoulis D contributed to this paper, the discussion and design of the manuscript; all authors have read and agreed to the published version of the manuscript.

Conflict-of-interest statement: All authors declare no conflict of interest in publishing the manuscript.

PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Grigorios Christodoulidis, MD, PhD, Department of General Surgery, University Hospital of Larissa, Mezourlo, Larissa 41110, Thessalia, Greece. gregsurg@yahoo.gr

Received: December 25, 2024
Revised: February 27, 2025
Accepted: March 10, 2025
Published online: May 24, 2025
Processing time: 145 Days and 15.6 Hours

Core Tip

Core Tip: Gastric neuroendocrine tumors are classified into three types, with type I and type II having a better prognosis, while type III presents a more aggressive course. Early diagnosis and treatment, including endoscopic resection and emerging therapies like Peptide Receptor Radionuclide Therapy, are key to improving outcomes, particularly for advanced cases. Further research is needed to enhance diagnostic accuracy and treatment options.